Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Business Daily.
Press releases published on August 13, 2025
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight
GlobeNewswire
·
August 13, 2025
New York, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight The rising demand for structural heart devices is largely …
Global Embolic Protection Devices Market Set to Experience Unprecedented Growth at a CAGR of ~8% by 2032 | DelveInsight
GlobeNewswire
·
August 13, 2025
New York, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global Embolic Protection Devices Market Set to Experience Unprecedented Growth at a CAGR of ~8% by 2032 | DelveInsight The demand for embolic protection devices is growing due to several important factors, …
Terra Balcanica Closes Fully Subscribed LIFE Offering
GlobeNewswire
·
August 13, 2025
Vancouver, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce the closing of the second and final tranche of its non-brokered, listed issuer financing …
NVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SPPI
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces the reopening of the Lead Plaintiff appointment process in a pending securities class action lawsuit on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Groupon, Inc. - GRPN
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
Spotify Renews Scam Junkie Podcast For Third Season
GlobeNewswire
·
August 13, 2025
Los Angeles, California , Aug. 13, 2025 (GLOBE NEWSWIRE) -- The award winning top rated true crime podcast, Scam Junkie has been renewed for its third season by Spotify Podcasts. Produced and hosted by former con man Steve Comisar aka Brett Champion, The …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. - DBI
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Designer Brands Inc. (“Designer Brands” or the “Company”) (NYSE: DBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. - KBR
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY). Such investors are advised to contact Danielle Peyton at newaction@ …
KINDERCARE LEARNING COMPANIES, INC. (NYSE: KLC) INVESTOR ALERT: Investors With Large Losses in KinderCare Learning Companies, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of KinderCare Learning Companies, …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of American Outdoor Brands, Inc. - AOUT
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of American Outdoor Brands, Inc. (“American Outdoor” or the “Company”) (NASDAQ: AOUT). Such investors are advised to contact Danielle Peyton at …
Lockheed Martin (LMT) Faces Investor Scrutiny Over Company’s Disclosures About Aeronautics and RMS Segments’ Performance, Securities Class Action Pending -- Hagens Berman
GlobeNewswire
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed …
Transaction in Own Shares
GlobeNewswire
·
August 13, 2025
Transaction in Own Shares 13 August, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 13 August, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to …
Sable Offshore Corp. (SOC) Hit With Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman
GlobeNewswire
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The …
Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline
GlobeNewswire
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the lead plaintiff process …
Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug - Hagens Berman
GlobeNewswire
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune ( …